The effect of unmodified or prestorage white cell-reduced allogeneic red cell transfusions on the immune responsiveness in orthopedic surgery patients

Transfusion

Volumn 39, Issue 7, 1999, Pages 718-723

  Bordin, José O ^a   Chiba, A K ^b   Carvalho, K I L ^b   Takata, E T ^b   Falcao R P ^b   Garcia, A B ^b   Bordin, I A S ^b   Maciel, M M ^b   Andreoni, S ^b   Kerbauy, J ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; NATURAL KILLER CELL; ORTHOPEDIC SURGERY; SURGICAL PATIENT; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY FORMATION; ARTHROPLASTY, REPLACEMENT, HIP; CELL COUNT; CYTOKINES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INTERLEUKIN-6; LEUKAPHERESIS; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032787984     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39070718.x     Document Type: Article

References (26)

1. Bordin JO, Blajchman MA. Transfusion-associated immunosuppression. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of transfusion medicine, vol 2. Baltimore: Williams & Wilkins, 1996;803-12.
2. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
3. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995;35:760-8.
4. Bordin JO, Blajchman MA. Immunosuppressive effects of allogeneic blood transfusions: implications for the patient with a malignancy. Hematol Oncol Clin North Am 1995;9:205-18.
5. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet 1993;342:1328-33; erratum appears Lancet 1994;343:64.
6. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996;36:175-86.
7. Vignali A, Braga M, Gianotti L, et al. A single unit of transfused allogeneic blood increases postoperative infections. Vox Sang 1996;71:170-5.
8. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet? Transfusion 1997;37:121-5.
9. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/ suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308-10.
10. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-516.
11. Meryman HT. Transfusion-induced alloimmunization and immunosuppression and the effect of leukocyte depletion. Transfus Med Rev 1989;3:180-93.
12. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
13. Welch HG, Meehan KR, Goodnough LT. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992;116:393-402.
14. Kirchner H, Kleinicke C, Digel W. A whole-blood technique for testing production of human interferon by leukocytes. J Immunol Methods 1982;48:213-9.
15. Tietze M, Klüter H, Troch M, Kirchner H. Immune responsiveness in orthopedic surgery patients after transfusion of autologous or allogeneic blood. Transfusion 1995;35:378-83.
16. Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood 1994;84:344-8.
17. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-5.
18. Houbiers JG, van de Velde CJ, van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997;37:126-34.
19. Tartter PI, Heimann TM, Aufses Jr AH. Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease. Am J Surg 1986;151:358-61.
20. Van Prooijen HC, Aarts-Riemens MI, van Oostendorp WR, et al. Prevention of donor-specific T-cell unresponsiveness after buffy-coat-reduced blood transfusion. Br J Haematol 1995;91:219-23.
21. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-98.
22. Strom TB, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996;8:688-93.
23. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992;53:1281-94.
24. Babcock GF, Alexander JW. The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse. Transplantation 1996;61:465-8.
25. Kirkley SA, Cowles J, Pellegrini Jr VD, et al. Cytokine secretion after allogeneic or autologous blood transfusion (letter). Lancet 1995;345:527.
26. Gafter U, Kalechman Y, Sredni B. Blood transfusion enhances production of T-helper-2 cytokines and transforming growth factor β in humans. Clin Sci 1996;91:519-23.